OROPHARYNGEAL CANCER STAGE UNSPECIFIED

This adverse event was reported 37 times

These drugs are most commonly taken by patients reporting OROPHARYNGEAL CANCER STAGE UNSPECIFIED:

# Drug Count
0 INFLIXIMAB 9
1 METHOTREXATE SODIUM 6
2 METHOTREXATE 5
3 ADALIMUMAB 3
4 FUROSEMIDE 3
5 ALENDRONATE SODIUM 2
6 ASPIRIN 2
7 ASPIRIN 325 MG 2
8 ASPIRIN 81 MG 2
9 ATORVASTATIN CALCIUM 2
See all common drugs associated with OROPHARYNGEAL CANCER STAGE UNSPECIFIED

OROPHARYNGEAL CANCER STAGE UNSPECIFIED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE 1 0.0023
1 SEVELAMER HYDROCHLORIDE 1 0.0017
2 CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE 1 0.0004
3 CLINDAMYCIN PHOSPHATE 2 0.0004
4 ESTROGEN 1 0.0003
5 CLINDAMYCIN PHOSPHATE TOPICAL 1 0.0003
6 PENTOXIFYLLINE 1 0.0002
7 LANTHANUM CARBONATE 1 0.0002
8 ERTAPENEM SODIUM 1 0.0001
9 HYOSCYAMINE SULFATE 1 0.0001
See all drugs enriched for association with OROPHARYNGEAL CANCER STAGE UNSPECIFIED